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Summary This paper describes a voluntary anonymous survey to investigate the
seroprevalence of Hepatitis C (HCV) in children in Glasgow, UK attending a Dental
Hospital and the proportion of HCV positive mothers who have a child who is HCV
seropositive. The study was undertaken among children and accompanying parents
and household contacts attending a general anaesthetic assessment clinic at Glasgow
Dental Hospital and School.
Children were asked to provide an oral fluid specimen for HCV testing. Accompa-
nying adults were asked to provide demographic data on the child and information on
familial risk factors for HCV infection using a standardised questionnaire. Birth moth-
ers were also asked to provide an oral fluid specimen. Specimens and questionnaires
were linked by a unique anonymous study number.Please cite this article in press as: O’Leary M, et al. The seroprevalence of hepatitis C virus infection among children
and their mothers attending for dental care in Glasgow, Scotland, United Kingdom. J Infect Public Health (2016),
http://dx.doi.org/10.1016/j.jiph.2016.08.001
Between June 2009 and December 2011, samples were collected from 2141 chil-
dren and 1698mothers. None of the samples from the children were HCV seropositive
but 16 (0.9%, 95% CI 0.6—1.5%) of the specimens from mothers were HCV antibody
positive.
∗ Corresponding author at: Glasgow Dental Hospital & School, 378 Sauchiehall Street, Glasgow G2 3JZ, United Kingdom.
E-mail address: jeremy.bagg@glasgow.ac.uk (J. Bagg).
ttp://dx.doi.org/10.1016/j.jiph.2016.08.001
876-0341/© 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
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In summary, the prevalence of HCV seropositivity in the birth mothers of the children
was similar to that estimated in the general population served by the hospital and
showed no evidence of mother-to-child transmission of HCV.
© 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
ed.
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the West of Scotland, recruited from the child
patient population attending the General Anaes-
thetic (GA) Assessment Clinic at the Glasgow DentalLimited. All rights reserv
Introduction
HCV is a major public health problem in Scotland,
with an estimated 38,000 individuals chronically
infected with the virus [1]. It is believed that
around half of those infected are undiagnosed
(approximately 18,000) and the majority have a his-
tory of injecting drug use [2].
A significant number of studies of the preva-
lence of HCV infection have been completed in a
variety of international locations, including both
endemic and non-endemic areas [3—20]. There
are few data on the prevalence of HCV in chil-
dren and, with the exception of a pilot study in
Glasgow [21], no prevalence surveys have been
conducted exclusively among children in the UK.
Many of the data on childhood prevalence glob-
ally have been derived from sub-analyses of larger
cross-sectional surveys of the general population
[3—5,7—9,12], though some have focused on chil-
dren [6,10,13—20]. There is worldwide geographic
variation in the prevalence of HCV infection in chil-
dren. With the exception of surveys of children from
African countries [8,9,17,18] the reported preva-
lence of HCV in children is usually very low and
frequently less than 1% [6,10,13—16,19,20].
Perinatal (vertical) transmission is widely
believed to be the most common source of HCV
infection in children [22]. The risk of transmission
from an HCV RNA positive mother at birth is
estimated at 5%, increasing with increasing viral
load, and almost entirely confined to those with
viral loads of ≥106/ml [23—25]. Transmission has
also been shown to be associated with mater-
nal history of injecting drug use [26]. Although
paternal HCV infection has been reported as a
risk factor for perinatal HCV infection, it is not
an independent risk factor, but is dependent on
maternal intravenous drug use [26].
There are an estimated 5000 people who inject
drugs (PWID) currently in the NHSGG&C health
board area aged between 15 and 54 years [27]Please cite this article in press as: O’Leary M, et al. The serop
and their mothers attending for dental care in Glasgow, Sco
http://dx.doi.org/10.1016/j.jiph.2016.08.001
and the prevalence of HCV in this population has
been reported as 68% [28]. While it is anticipated
that children of current and former PWIDs will be
H
et increased risk of HCV infection, little is known
bout the prevalence of HCV in children in this geo-
raphical area. A previous pilot study in Glasgow
21], which assessed the feasibility and accept-
bility of recruiting children for an anonymous
ross-sectional survey of HCV infection using an oral
uid collection device, reported a prevalence of
.9% (2/70, 95% CI: 0.35—9.9), which was higher
han in the general Scottish population, where the
revalence is approximately 1% [1]. Although the
ample size for the study was small, the surpris-
ngly high prevalence rate reported in this study
nderscored the need to investigate HCV preva-
ence in the paediatric population in Scotland. The
igh prevalence rate was thought likely to reflect
he large population of current and former inject-
ng drug users who reside in Glasgow and the high
evel of social deprivation of the population who
ttend the Dental Hospital and School.
The primary objective of this study was, there-
ore, to determine the seroprevalence of HCV
mong children in Glasgow. Secondary objectives
ere to determine the association between mark-
rs of HCV infection in mothers and children, and to
dentify risk-factors for HCV infection in children.
his information is important in order to inform
hether case finding of children living in house-
olds with guardians who inject is required, and the
reatment, care and support needs for this popu-
ation, which in the USA have been identified as
ubstantial [29].
ethods
tudy design
cross-sectional survey of children, and when pos-
ible their birth mothers, resident in Glasgow andrevalence of hepatitis C virus infection among children
tland, United Kingdom. J Infect Public Health (2016),
ospital and School, for assessment prior to dental
xtraction.
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ecruitment of participants
rior to each child’s attendance at the clinic, an
nvitation letter and information leaflet was sent to
arents/guardians along with the child’s appoint-
ent card, in order to inform them of the study.
pon attendance, a research nurse approached par-
nts/guardians, explained the study and procedure
n detail and invited them to provide informed
ritten consent for the child to participate in the
urvey. Children aged over seven years were also
sked to provide written consent and children aged
ess than seven years were asked to assent verbally
o participate. The investigator employed a vari-
ty of communication strategies, including play, to
ommunicate with the children, in particular pre-
chool children.
Children were excluded from the study if they
ere accompanied by a guardian who did not have
arental rights to consent for them to participate;
ere not attending the clinic for assessment; or
ere aged less than 3 years and more than 14 years.
ata collection and handling
he Research Nurse interviewed the par-
nts/guardians to collect anonymous demographic
nd risk factor data for HCV infection for the child
nd mothers using a standardised questionnaire.
ge, gender and ethnic background of participants
ere recorded, together with post-code data to
llow a deprivation category to be assigned to
ach participant. In addition, for each child, data
ere recorded on recognised risk factors for HCV
nfection (blood transfusion, organ transplant,
urgery, tattoos and piercings and overseas med-
cal treatment); co-habitation with a parent or
ther household member who was a current or
ormer injecting drug user; co-habitation with a
arent or other household member who was HCV
ositive; risk factors for intra-familial horizontal
ransmission (including sharing toothbrushes); risk
actors for vertical transmission (maternal HCV
nfection, maternal HCV/HIV co-infection, mode
f delivery at birth) and maternal country of birth.
he maternal risk factors for infection collected
ere intravenous drug use, history of blood trans-
usion or organ transplant and overseas medical
reatment. Household contacts were identified
sing the definition used in the 2001 Scottish
ensus, as ‘‘a group of people (not necessarily
elated) living at the same address with commonPlease cite this article in press as: O’Leary M, et al. The sero
and their mothers attending for dental care in Glasgow, Sc
http://dx.doi.org/10.1016/j.jiph.2016.08.001
ousekeeping, sharing either a living room or
itting room, or at least one meal a day’’.
Data collected on those who declined to partic-
pate were the age and gender of the child, the
v
p
t
u PRESS
3
elationship of the accompanying adult to the child
nd the reason for non-consent, to allow assess-
ent of any response bias.
Data were entered on a daily basis into a
assword protected Microsoft Access database on
secure password protected computer. Post-code
ata were automatically converted to a social
eprivation category using the Scottish Index of
ultiple Deprivation (SIMD), then redacted on
he questionnaire and rendered unreadable, in
rder to protect patient confidentiality. All data
ere held in accordance with the Caldicott guide-
ines (http://www.connectingforhealth.nhs.uk/
ystemsandservices/infogov/caldicott)
nd the Data Protection Act 1998
http://www.legislation.gov.uk/
kpga/1998/29/contents).
aliva specimen collection
aliva specimens were collected from both chil-
ren and birth mothers using the OraSure collection
evice (Epitope Inc., Oregon, USA). Participants
ere asked to insert the device into their mouth
etween the lower cheek and gum and retain it
or two minutes. Specimens were placed into a
abelled vial and stored at  −40 ◦C before transport
o the West of Scotland Specialist Virology Centre
WSSVC) for testing. Specimens from a child and
dult were linked to the questionnaire data using a
nique anonymous number.
aboratory testing
ral fluid specimens were tested for HCV antibodies
sing amodified protocol for the Ortho HCV 3.0 SAVe
LISA (Product number 940982, Ortho Diagnostics
mersham). The sensitivity and specificity of this
ssay are 92% and 99% respectively [30] All reactive
amples were repeated using the same assay and
eakly reactive samples were further tested using
odified protocols of the recombinant immunoblot
ssay (RIBA). The virology laboratory held a secure
icrosoft Access database containing the unique
nonymous study number, date of HCV test, sample
iability and HCV antibody test result, which was
erged on a quarterly basis with the main study
atabase.
ata analysis
ll statistical analyses were carried out using SPSSprevalence of hepatitis C virus infection among children
otland, United Kingdom. J Infect Public Health (2016),
ersion 17 and STATA version 9.2. Results were
resented as numbers and percentages. Represen-
ativeness of the study population was assessed
sing chi-square test comparing the gender, age,
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Figure 1 Recruitment and hepatitis C testing of participants in the hepatitis C prevalence survey of children at
Glasgow Dental Hospital and School, August 2009 to December 2011.
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sethnicity and relationship with accompanying adult
of the participants and non-participants. HCV
prevalence is presented with the 95% confidence
limits (Cl) calculated using the Wilson method for
small n. Factors associated with maternal HCV
infection were determined using univariable logis-
tic regression analysis. Associations were expressed
as odds ratio (OR) together with their 95% CI.
Multivariable logistic regression analysis was not
performed due to the collinearity of the predictor
variablesPlease cite this article in press as: O’Leary M, et al. The serop
and their mothers attending for dental care in Glasgow, Sco
http://dx.doi.org/10.1016/j.jiph.2016.08.001
Results
Of the 3111 children attending the General
Anaesthetic (GA) Assessment Clinic at Glasgow Den-
o
(
tal Hospital and School during the recruitment
eriod, 259 did not meet the inclusion criteria
nd were excluded. Of those eligible to partic-
pate (n = 2852), 2141 consented to participate
n the survey giving an overall participation rate
f 75% (Fig. 1). Compared to participants, non-
articipants tended to be younger (P  ≤ 0.001) and
on-Caucasian (P  ≤ 0.001) (Table 1).
Of the 2141 children participating, 1141 (53%)
ere female and 1333 (62%) aged between 3—6
ears. Fifty nine percent of children participating
ere resident in areas of Glasgow considered to be
he most deprived (SIMD quintile 4 and 5). Sixty
even children (3.1%) reportedly lived with some-revalence of hepatitis C virus infection among children
tland, United Kingdom. J Infect Public Health (2016),
ne who had a history of drug use; of these 31
46.3%) also lived with someone who was HCV posi-
ive. One hundred and three (4.8%) children were of
ARTICLE IN PRESSJIPH-614; No. of Pages 9
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Table 1 Comparison of characteristics of participants and non-participants in the eligible study population
(n = 2855).
Characteristic Non participantsn = 711% (n) Participantsn = 2141% (n) p-valuea
Sex
Female 49.6 (353) 46.7 (1000)
Male 50.4 (358) 53.3 (1141) NS
Age-group (years)
3—6 72.7 (517) 62.3 (1333)
7—10 23.6 (168) 29.8 (638)
11—14 3.6 (26) 7.9 (170) <0.001
Ethnicity
Caucasian 79.7 (567) 92.0 (1970)
South Asian 11.0 (78) 4.8 (103)
Other 9.2 (66) 3.2 (68) <0.001
Relationship of accompanying adult
Mother 83.1 (591) 79.4 (1700)
Father 16.5 (117) 18.4 (395) 0.004
Guardian lives with child 0.4 (3) 2.12 (46)
NS is not significant at 5% level.
a Chi-square test.
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mouth Asian ethnicity. Ten (9.7%) lived with, and 12
11.6%) had contact with, someone who was HCV
ositive. Twenty four children (1.15%) were living
ith someone who was HCV positive but did not
ive with someone who had a history of drug use or
ere of South Asian ethnicity. All children provided
n oral fluid specimen for HCV antibody testing, and
ero (0%, 95% CI 0—0.2%) were antibody positive
Oral fluid specimens were obtained from the
ajority of birth mothers accompanying their chil-
ren (n = 1698, 99.3%). Sixteen birth mothers (0.9%,
5% CI 0.6—1.5%) were HCV antibody positive.
alf of the HCV antibody positive mothers were
ware of their HCV positive status at the time of
nterview. Factors associated with maternal HCV
ntibody were South Asia place of birth (P = 0.03)
nd history of injecting drug use (P < 0.001). In
ddition to South Asia place of birth (P = 0.001),
eceipt of medical treatment overseas (P = 0.007)
as also associated with maternal HCV antibody
hen mothers with a history of injecting drug use
ere excluded from the analysis (Table 2).
iscussion
here are no data on HCV infection in the childPlease cite this article in press as: O’Leary M, et al. The sero
and their mothers attending for dental care in Glasgow, Sc
http://dx.doi.org/10.1016/j.jiph.2016.08.001
opulation of the UK, although the prevalence
s expected to be much lower than in the adult
opulation. In Scotland, approximately 0.8% of
he population aged 15—59 years had been diag-
o
t
hosed HCV antibody positive by the end of 2014.
he largest proportion of the diagnosed individuals
esides in the NHS Greater Glasgow and Clyde Board
rea. Those at greatest risk of infection include past
nd current people who inject drugs and individuals
f South Asian origin [1,31]. It is therefore possible
hat children of infected women with a history of
njecting drugs will be at the greatest risk. Children
orn to migrants from HCV endemic areas may also
e at increased risk.
A high proportion of children attending the
eneral anaesthetic assessment clinic at Glasgow
ental Hospital and School come from areas of high
ocial deprivation. They are more likely to be from
amilies with a history of injecting drug use and
herefore more likely to have a family member
ho is infected with HCV. While the prevalence
f HCV antibodies in participants from medium
o low deprivation areas (SIMD deciles 4—6) was
s expected (0.4%), the prevalence among those
ecruited from high deprivation areas (SIMD 1—3)
as lower than expected (1.3% compared to an
nticipated 4%).
The overall HCV antibody prevalence in the
others recruited to this study is consistent with
he epidemiology of HCV infection among the
eneral population of Scotland [1]. As expected,
others with a history of injecting drug use or thoseprevalence of hepatitis C virus infection among children
otland, United Kingdom. J Infect Public Health (2016),
f South Asian origin were significantly more likely
o be HCV antibody positive. These groups were,
owever, under-represented, with only 1.5% and
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Table 2 Factors associated with HCV Ab prevalence among mothers of children attending Glasgow Dental Hospital, 2009—2011.
Prevalence of HCV
antibodies (all)
Univariate analysis
all
Prevalence of HCV
antibodies
(excluding PWID)
Univariate analysisb
excluding PWID
Total N n % of N 95% CI OR 95% CI P Total N n % of N 95% CI OR 95% CI P
All 1698 16 0.9 0.6 1.5 1684 10 0.6 0.3 1.0
Deprivationa (NR = 1)
Most deprived 1026 13 1.3 0.7 2.2 1.0c 1017 10 0.9 0.5 1.8 1.0c
Less deprived 671 3 0.4 0.2 1.3 0.4 0.1 1.2 0.1 666 0 0.0 0.0 0.5 0.2 0.0 1.3 NS
Maternal place of birth
UK 1608 13 0.8 0.5 1.4 1.0c 1595 7 0.4 0.2 0.9 1.0c
South Asia 28 2 7.1 2.0 22.6 9.5 2.0 44.0 0.004 28 2 7.1 2.0 22.6 17.5 3.5 88.1 0.001
Other 62 1 1.6 0.3 8.6 4.7 0.3 15.6 NS 61 1 1.6 0.3 8.7 3.8 0.5 31.2 0.221
Previous blood transfusion (NR = 13)
No 1515 14 0.9 0.6 1.6 1.0c 1504 10 0.7 0.4 1.2 1.0c
Yes 170 2 1.2 0.3 4.2 1.3 0.3 5.7 NS 167 0 0 0 2.2 1.0 0.1 7.9 NS
Overseas medical treatment (NR = 3)
No 1589 13 0.8 0.5 1.4 1.0c 1577 7 0.4 0.2 0.9 1.0c
Yes 106 3 2.8 1.0 8.2 3.5 1.0 12.6 0.05 104 3 2.9 1.0 8.1 6.7 1.7 26.1 0.007
History of injecting drug use (NR = 16)
No 1684 10 0.6 0.3 1.1 1.0c
Yes 14 6 42.9 21.4 67.8 125.2 36.8 428.5 <0.001
NR= non response.
Bold values signifies statistical significance.
a Most deprived = simdquintile 1—3; less deprived = simdquintile 4 & 5.
b Sampling zeros were managed by adding one to each zero cell.
c Baseline.
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CV seroprevalence in children and mothers
.5% of the final sample reporting to be of South
sian origin or providing a history of injecting drug
se respectively. The prevalence in both groups was
igher than that reported previously, but the fig-
res are based on small numbers [28,31]. Given the
mall number of HCV positive mothers in the sam-
le, it is perhaps not surprising that no HCV positive
hildren were identified. The prevalence of HCV
ntibodies in this study was lower than that pre-
iously reported in a small pilot study undertaken
n the same clinic setting [21]. The pilot study did
ot collect any demographic or risk information on
he participants or their mothers, and the reasons
or the observed difference are unknown.
There are a number of possible explanations for
he small proportion of mothers in the final sample
ith a recognised risk for HCV infection. First, self-
xclusion of mothers who had a history of injecting
rug use is likely, as 32% of adults accompanying
he child to the clinic indicated that the reason
or non-participation was their unwillingness to dis-
lose risk factors; it is not known whether these
ndividuals were more likely to be infected. Self-
xclusion of mothers who knew that they or their
hildren were already infected with HCV is also
ossible. Second, non-disclosure of a previous risk
or HCV is also plausible. Indeed, only half of the
CV antibody positive mothers disclosed a recog-
ised risk factor(s) at the point of recruitment.
hird, the under-representation of those from S.
sia in the final sample may have been a result of
ewer children being accompanied by their birth
other when compared with the Caucasian chil-
ren (60% versus 86%) or as a consequence of a
anguage barrier, though fewer than 2% of those
ligible to participate specifically mentioned this
s a reason for non-participation. Finally, the study
rotocol excluded any child who attended with an
dult who did not have parental rights to consent to
he child’s participation. Certain adults who are ‘in
oco parentis’ such as foster parents or social work-
rs may accompany children who are more likely
o come from areas of deprivation or to have par-
nts with a history of drug use. Under-recruitment
f such children may have led to an underestima-
ion of HCV prevalence in our child population.
owever, our data indicate that only 17 children
ere accompanied by a social worker or a foster
arer.
As the mothers at greatest risk of HCV infec-
ion are under-represented, there is the possibility
hat HCV antibody positive children may have beenPlease cite this article in press as: O’Leary M, et al. The sero
and their mothers attending for dental care in Glasgow, Sc
http://dx.doi.org/10.1016/j.jiph.2016.08.001
issed. If we assume that the participants are sim-
lar in all other respects, we might estimate (by
pplying the prevalences found) that we missed
our HCV antibody positive mothers who were born
F
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utwith the UK; four HCV antibody positive moth-
rs who had received treatment outwith the UK
most likely these being the same individuals) and
2 HCV antibody positive mothers who had a his-
ory of injecting drug use. Therefore, overall there
ay have been 42 HCV infected mothers in the pop-
lation eligible to participate. If we assume 75%
hronicity and 5% HCV transmission rate we might
ave expected one HCV antibody positive child to
e identified.
The strengths of this study were our large sample
ize of healthy children with paired maternal and
hild specimens for HCV antibody testing linked to
isk information for HCV infection from both mother
nd child. In addition, our study was conducted in
clinic that treats a large number of children from
reas of high level social deprivation that include
large population of current and former injecting
rug users.
There were three key limitations to the study.
irst, there was the risk that mothers who believed
hey were at risk of HCV infection chose not to
ake part. We know this was an issue in this vol-
ntary study and it is a pertinent reminder of the
hallenges of voluntary surveys of children where
he maternal risk can be stigmatising and fear of
ocial care interventions can prevent participation
nd/or disclosure. Secondly, while the decision to
ollect a non invasive saliva specimen was taken
o encourage participation of children, the sen-
itivity of the assay we used was only 92% and
e were unable to establish chronic infection.
inally, we have assumed that the HCV-seropositive
omen were positive at the time of birth of
he child, but this may not have been the case,
ince infection may have occurred after the preg-
ancy.
In conclusion, despite the limitations alluded
o above, this study showed that the prevalence
f HCV infection in the birth mothers of children
ttending a General Anaesthetic pre-assessment
linic prior to dental extractions was similar to
he estimate of infection in the general popula-
ion served, and showed no evidence of mother to
hild transmission in this small group of infected
ndividuals. However, given the introduction of
ighly effective antiviral treatment for hepatitis
, resources should be concentrated on identifying
nd testing infants born to HCV infected women.prevalence of hepatitis C virus infection among children
otland, United Kingdom. J Infect Public Health (2016),
unding
cottish Government, Hepatitis C Action Plan.
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